#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ornithine transcarbamoylase deficiency Hypersomnia Adenocarcinoma pancreas Porphyria non-acute Neoplasm malignant Congenital generalised lipodystrophy Interstitial lung disease Cluster headache Acquired ATTR amyloidosis Ventricular fibrillation Mantle cell lymphoma stage IV Staphylococcal infection Acute graft versus host disease in skin Pancreatic carcinoma metastatic Mixed-type liposarcoma More trials…

    Learn about Rare Diseases

    Fabry’s disease Behcet’s syndrome – Treatment Crigler-Najjar syndrome – Basic Information Waldenstrom’s macroglobulinaemia recurrent Myxofibrosarcoma – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Hepatic angiosarcoma – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Hairy cell leukaemia Choroid melanoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CC-97540 Lovotibeglogene Autotemcel Eletriptan Bjt-778 PRILOCAINE HYDROCHLORIDE Glycerol Phenylbutyrate Azd8421 Incb000928 Rondaptivon Pegol A3907 Amoxicillin Trihydrate Threonine Regorafenib Tigulixostat Lenvatinib Oditrasertib NALOXEGOL Rp-1664 Sulfate Tezacaftor Sargramostim More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Generalised anxiety disorder Thalassaemia beta Glomerulonephritis acute Neuromyopathy Progressive multiple sclerosis Senile dementia Invasive breast carcinoma Desmoplastic melanoma Sinus rhythm Retinitis pigmentosa Herpes virus infection Vaginal cancer Ocular myasthenia Primary hyperoxaluria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gestational trophoblastic tumour

  • Study on the Safety and Effectiveness of Domvanalimab and Zimberelimab for Adults with Advanced Rare Cancers Resistant to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic thyroid cancer
    • Thymic carcinoma
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • Domvanalimab
    • Fluorouracil
    • Folinic Acid
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!